Literature DB >> 7684359

Induction of an auto-anti-IgE response in rats. IV. Effects on mast cell degranulation.

G Jaffery1, E B Bell, J W Coleman.   

Abstract

Induction of an auto-anti-IgE (auto-aIgE) response in the rat inhibits both total and specific IgE production and alters the distribution of mast cell (MC) subpopulations identified by differential Alcian blue/safranin staining. We have extended these observations by characterizing the auto-aIgE antibodies and determining their effects on MC degranulation in vitro and in vivo. An auto-aIgE response was induced in bacillus Calmette-Guérin (BCG)-primed rats by injecting a conjugate of highly purified rat IgE myeloma (IR2) coupled to tuberculin-derived purified protein derivative (PPD). Anti-IgE autoantibodies were almost exclusively IgG2a. The intradermal injection of auto-aIgE into untreated rats induced local MC degranulation as shown by a strong immediate skin response. Histologically there was evidence of significant degranulation of safranin staining connective tissue MC (SMC) in the skin but not of the Alcian blue staining MC (ABMC) in the sub-epidermal region. The induced degranulation was epsilon-chain specific; immunopurified anti-idiotypic antibodies raised to the IgE IR2 myeloma had no MC degranulating activity. When administered locally, auto-aIgE inhibited a subsequent passive cutaneous anaphylaxis (PCA) response elicited by anti-ovalbumin IgE. In addition, the PCA response was significantly decreased in animals with an ongoing auto-aIgE response. Immunopurified auto-aIgE also induced histamine release in vitro from rat peritoneal MC. These results are discussed in the context of naturally occurring autoantibodies to IgE present in patients with allergic disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684359      PMCID: PMC1421891     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor.

Authors:  J S Marshall; R H Stead; C McSharry; L Nielsen; J Bienenstock
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

2.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE.

Authors:  S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Induction of an auto-anti-IgE response in rats. III. Inhibition of a specific IgE response.

Authors:  J S Marshall; E B Bell
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

5.  The effect of polymyxin B and some mast-cell constituents on mucosal mast cells in the duodenum of the rat.

Authors:  L Enerbäck; G Löwhagen; O Löwhagen; U Wingren
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

6.  A new concept of triggering mechanisms of IgE-mediated histamine release.

Authors:  T Ishizaka; K Ishizaka; D H Conrad; A Froese
Journal:  J Allergy Clin Immunol       Date:  1978-05       Impact factor: 10.793

7.  Anti-IgE autoantibody in patients with bronchial asthma.

Authors:  Y Nawata; T Koike; T Yanagisawa; I Iwamoto; T Itaya; S Yoshida; H Tomioka
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

8.  Anti-IgE antibodies in human serum: occurrence and specificity.

Authors:  M Inganäs; S G Johansson; H Bennich
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

9.  Accelerated elimination of N. brasiliensis from the small intestine after auto-anti-IgE induction.

Authors:  J S Marshall; P D Wells; E B Bell
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

10.  Maturation of rat mast cells. An electron microscope study.

Authors:  J W Combs
Journal:  J Cell Biol       Date:  1966-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.